Literature DB >> 9438490

Prolonged acute exposure to 0.16 ppm ozone induces eosinophilic airway inflammation in asthmatic subjects with allergies.

D B Peden1, B Boehlecke, D Horstman, R Devlin.   

Abstract

BACKGROUND: Increased ambient ozone levels have been associated with increased asthma morbidity in epidemiologic studies. Given that asthma is characterized by airway inflammation and increased sensitivity to airway irritants, it has been suggested that asthmatic subjects may be particularly sensitive to the effect of ozone.
OBJECTIVE: The objective of this study was to determine whether exposure to 0.16 ppm ozone induces eosinophilic inflammation in the lower airways of asthmatic subjects.
METHODS: Eight asthmatic subjects sensitive to mites were exposed to 0.16 ppm ozone and clean air on separate occasions no less than 4 weeks apart in a double-blind, randomized fashion followed by bronchoscopy 18 hours later. Bronchoalveolar lavage fluid and bronchial lavage fluid were examined for eosinophils.
RESULTS: Ozone induced significant increases in airway eosinophils, especially in bronchial lavage fluid.
CONCLUSIONS: Ozone exposure results in increased eosinophilic inflammation in the lower airways of asthmatic subjects with allergies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9438490     DOI: 10.1016/s0091-6749(97)70277-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  22 in total

Review 1.  The effect of environmental oxidative stress on airway inflammation.

Authors:  Amy Auerbach; Michelle L Hernandez
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-04

2.  Air pollution and asthma severity in adults.

Authors:  E Rage; V Siroux; N Künzli; I Pin; F Kauffmann
Journal:  Occup Environ Med       Date:  2008-11-18       Impact factor: 4.402

Review 3.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

4.  Low-level ozone exposure induces airways inflammation and modifies cell surface phenotypes in healthy humans.

Authors:  Neil E Alexis; John C Lay; Milan Hazucha; Bradford Harris; Michelle L Hernandez; Philip A Bromberg; Howard Kehrl; David Diaz-Sanchez; Chong Kim; Robert B Devlin; David B Peden
Journal:  Inhal Toxicol       Date:  2010-06       Impact factor: 2.724

Review 5.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

6.  Atopic asthmatic subjects but not atopic subjects without asthma have enhanced inflammatory response to ozone.

Authors:  Michelle L Hernandez; John C Lay; Bradford Harris; Charles R Esther; W June Brickey; Philip A Bromberg; David Diaz-Sanchez; Robert B Devlin; Steven R Kleeberger; Neil E Alexis; David B Peden
Journal:  J Allergy Clin Immunol       Date:  2010-09       Impact factor: 10.793

7.  ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation.

Authors:  Istvan Boldogh; Attila Bacsi; Barun K Choudhury; Nilesh Dharajiya; Rafeul Alam; Tapas K Hazra; Sankar Mitra; Randall M Goldblum; Sanjiv Sur
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  Ragweed as an example of worldwide allergen expansion.

Authors:  Matthew L Oswalt; Gailen D Marshall
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

9.  Postnatal exposure history and airways: oxidant stress responses in airway explants.

Authors:  Shannon R Murphy; Edward S Schelegle; Patricia C Edwards; Lisa A Miller; Dallas M Hyde; Laura S Van Winkle
Journal:  Am J Respir Cell Mol Biol       Date:  2012-09-06       Impact factor: 6.914

10.  Association of ambient ozone exposure with airway inflammation and allergy in adults with asthma.

Authors:  Sumita B Khatri; Fernando C Holguin; P Barry Ryan; David Mannino; Serpil C Erzurum; W Gerald Teague
Journal:  J Asthma       Date:  2009-10       Impact factor: 2.515

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.